Rawan Omar - العربية

Rawan's inventions include flexible, biocompatible, and biodegradable nanosensor platforms for continuous health monitoring and early disease diagnosis. Designed to be wearable or implantable, these nanosensors detect critical biomarkers like metabolites (e.g., lactate, glucose), chemical biomarkers (e.g., pH, volatile organic compounds), and electrolytes (e.g., calcium, sodium, potassium), from body fluids and tissues. The wearable nanosensors are developed as flexible microneedle-based extended gate field-effect transistors (MN-EGFET), enabling real-time, painless detection of biomarkers from interstitial fluids in the thin layer of the skin, particularly in the epidermis and upper dermis. The implantable nanosensors, made from entirely biocompatible and biodegradable materials such as magnesium and zinc nanoparticles, designed to measure health parameters like lactate, pressure, and volatile organic compounds. These nanosensors degrade naturally after finishing their intended use. Both sensor types are integrated with AI-predictive models and IoT technologies, allowing continuous data transmission and analysis for early disease detection and personalized health management. What sets this innovation apart is the seamless integration of advanced nanosensor technology with high biomarker selectivity, rapidity, precision, and sensitivity, combined with IoT and AI capabilities for continuous health management. Rawan's future plans focus on commercializing and advancing the technology for broader applications and greater impact.